Harrow Health, Inc. (NASDAQ:HROW) Q4 2022 Earnings Call Transcript

Mark Baum: Thank you. And as I also said in my Letter to Stockholders, the phenomenal effort of the Harrow family led to the achievement of even more than I had dared hoped for. Our achievements to-date including the fact that Harrow is in the best financial and operational shape of its history would not have been possible without the tenacity and hard work of our team, nor would it be possible without the financial support of our stockholders, all of you, many of whom have been with us through thick and thin, good and bad days. I look forward to rewarding those stockholders for their patience and their trust and for helping us to deliver on our mission to make great pharmaceutical products that are accessible, affordable and to stay focused on the unmet needs of the eye care professionals and their patients that we serve.

Thanks to everyone for attending today’s call and for your interest in Harrow. If you have any Investor related questions, please email Jamie Webb at jwebb@harrowinc.com. This will conclude our call.

Operator: The conference has now concluded. Thank you for attending today’s presentation. You may now disconnect.